SCHEMBL30264704

SCHEMBL30264704

COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3F)c2cc1I

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.66
KDR P35968 11/20 0.61
EPHA2 P29317 10/20 0.61
ERBB2 P04626 10/20 0.61
EPHB4 P54760 9/20 0.61
FLT1 P17948 8/20 0.61
EPHB2 P29323 3/20 0.60
SRC P12931 3/20 0.60
RET P07949 3/20 0.60
RIPK2 O43353 2/20 0.60
EPHA4 P54764 2/20 0.60
BTK Q06187 2/20 0.60
RIPK3 Q9Y572 2/20 0.60
GAK O14976 1/20 0.60
EPHB6 O15197 1/20 0.60
STK10 O94804 1/20 0.60
MAP4K4 O95819 1/20 0.60
ABL1 P00519 1/20 0.60
LCK P06239 1/20 0.60
YES1 P07947 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16075706 0.88 EGFR (0.67) EGFRKDREPHA2ERBB2EPHB4
SCHEMBL30792543 0.87 EGFR (0.66) EGFRKDREPHA2ERBB2EPHB4
SCHEMBL29453257 0.87 EGFR (0.70) EGFRKDREPHA2ERBB2EPHB4
SCHEMBL30459542 0.87 EGFR (0.70) EGFRKDREPHA2ERBB2EPHB4
SCHEMBL14843536 0.87 EGFR (0.70) EGFRKDREPHA2ERBB2EPHB4
SCHEMBL19124462 0.87 EGFR (0.66) EGFRKDREPHA2ERBB2EPHB4
SCHEMBL21541684 0.87 EGFR (0.66) EGFRKDREPHA2ERBB2EPHB4
SCHEMBL30264723 0.87 EGFR (0.63) EGFRKDREPHA2ERBB2EPHB4
SCHEMBL19124214 0.86 EGFR (0.67) EGFRKDREPHA2ERBB2EPHB4
Hydrochloric Acid SCHEMBL28028283 0.86 EGFR (0.65) EGFRKDREPHA2ERBB2EPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392423-A1 QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE Arthrosi Therapeutics, Inc. (US) 2024-07-03 EP disclosed
WO-2023028054-A1 QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE ARTHROSI THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed